Hailey–Hailey disease treated with dupilumab: a case series

British Journal of DermatologyVolume 185, Issue 3 p. 680-682 Research letter Hailey–Hailey disease treated with dupilumab: a case series N. Alzahrani, N. Alzahrani orcid.org/0000-0003-3417-9945 King Abdulaziz University, Jeddah, Saudi Arabia Contribution: Conceptualization (equal), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this authorJ. Grossman-Kranseler, J. Grossman-Kranseler Department of Dermatology, Tufts Medical Center, Boston, MA, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal), Visualization (equal), Writing - review & editing (equal)Search for more papers by this authorR. Swali, R. Swali orcid.org/0000-0002-3052-2382 Center for Clinical Studies, Houston, TX, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal), Visualization (equal)Search for more papers by this authorK. Fiumara, K. Fiumara Clinical Pharmacy, Tufts Medical Center, Boston, MA, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal)Search for more papers by this authorP. Zancanaro, P. Zancanaro Department of Dermatology, Tufts Medical Center, Boston, MA, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal)Search for more papers by this authorS. Tyring, S. Tyring McGovern Medical School at University of Texas Health Science Center, Houston, TX, USA Contribution: Conceptualization (equal), Supervision (equal), Validation (equal), Visualization (equal)Search for more papers by this authorD. Rosmarin, Corresponding Author D. Rosmarin drosmarin@tuftsmedicalcenter.org orcid.org/0000-0003-2786-0708 Department of Dermatology, Tufts Medical Center, Boston, MA, USA Correspondence: David Rosmarin. Email: drosmarin@tuftsmedicalcenter.org Contribution: Conceptualization (equal), Data curation (equal), Project administration (equal), Supervision (lead), Validation (lead)Search for more papers by this author N. Alzahrani, N. Alzahrani orcid.org/0000-0003-3417-9945 King Abdulaziz University, Jeddah, Saudi Arabia Contribution: Conceptualization (equal), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this authorJ. Grossman-Kranseler, J. Grossman-Kranseler Department of Dermatology, Tufts Medical Center, Boston, MA, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal), Visualization (equal), Writing - review & editing (equal)Search for more papers by this authorR. Swali, R. Swali orcid.org/0000-0002-3052-2382 Center for Clinical Studies, Houston, TX, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal), Visualization (equal)Search for more papers by this authorK. Fiumara, K. Fiumara Clinical Pharmacy, Tufts Medical Center, Boston, MA, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal)Search for more papers by this authorP. Zancanaro, P. Zancanaro Department of Dermatology, Tufts Medical Center, Boston, MA, USA Contribution: Conceptualization (equal), Data curation (equal), Supervision (equal), Validation (equal)Search for more papers by this authorS. Tyring, S. Tyring McGovern Medical School at University of Texas Health Science Center, Houston, TX, USA Contribution: Conceptualization (equal), Supervision (equal), Validation (equal), Visualization (equal)Search for more papers by this authorD. Rosmarin, Corresponding Author D. Rosmarin drosmarin@tuftsmedicalcenter.org orcid.org/0000-0003-2786-0708 Department of Dermatology, Tufts Medical Center, Boston, MA, USA Correspondence: David Rosmarin. Email: drosmarin@tuftsmedicalcenter.org Contribution: Conceptualization (equal), Data curation (equal), Project administration (equal), Supervision (lead), Validation (lead)Search for more papers by this author First published: 10 May 2021 https://doi.org/10.1111/bjd.20475 Funding sources: Pfizer Inflammatory and Immune-mediated Skin Diseases Fellowship funded the study. The funding organization had no role in the design and conduct of the study; in the collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication. Conflicts of interest: D.R. has received honoraria as a consultant for AbbVie, AltruBio, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Concert Pharmaceuticals, Dermavant, Dermira, Incyte, Janssen Pharmaceuticals, Kyowa Kirin, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals, Sanofi, Sun Pharmaceutical Industries Limited, UCB and Viela Bio (Horizon); has received research support from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Dermira, Galderma, Incyte, Janssen, Lilly, Merck, Novartis, Pfizer and Regeneron; and has served as a paid speaker for AbbVie, Amgen, Celgene, Janssen, Lilly, Novartis, Pfizer, Regeneron and Sanofi. The other authors declare they have no conflicts of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume185, Issue3September 2021Pages 680-682 RelatedInformation